|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:HERC2-COL5A2 (FusionGDB2 ID:36012) |
Fusion Gene Summary for HERC2-COL5A2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: HERC2-COL5A2 | Fusion gene ID: 36012 | Hgene | Tgene | Gene symbol | HERC2 | COL5A2 | Gene ID | 8924 | 1290 |
| Gene name | HECT and RLD domain containing E3 ubiquitin protein ligase 2 | collagen type V alpha 2 chain | |
| Synonyms | D15F37S1|MRT38|SHEP1|jdf2|p528 | EDSC|EDSCL2 | |
| Cytomap | 15q13.1 | 2q32.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | E3 ubiquitin-protein ligase HERC2HECT-type E3 ubiquitin transferase HERC2hect domain and RCC1-like domain-containing protein 2hect domain and RLD 2probable E3 ubiquitin-protein ligase HERC2 | collagen alpha-2(V) chainAB collagencollagen, fetal membrane, A polypeptidetype V preprocollagen alpha 2 chain | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | . | P05997 | |
| Ensembl transtripts involved in fusion gene | ENST00000261609, ENST00000563945, | ENST00000374866, | |
| Fusion gene scores | * DoF score | 14 X 12 X 9=1512 | 8 X 9 X 4=288 |
| # samples | 15 | 9 | |
| ** MAII score | log2(15/1512*10)=-3.33342373372519 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(9/288*10)=-1.67807190511264 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: HERC2 [Title/Abstract] AND COL5A2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | HERC2(28538034)-COL5A2(189940163), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | HERC2 | GO:0006974 | cellular response to DNA damage stimulus | 22508508 |
| Hgene | HERC2 | GO:0016567 | protein ubiquitination | 20304803 |
| Tgene | COL5A2 | GO:1903225 | negative regulation of endodermal cell differentiation | 23154389 |
| Fusion gene breakpoints across HERC2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across COL5A2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | LUAD | TCGA-L9-A5IP | HERC2 | chr15 | 28538034 | - | COL5A2 | chr2 | 189940163 | - |
Top |
Fusion Gene ORF analysis for HERC2-COL5A2 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| In-frame | ENST00000261609 | ENST00000374866 | HERC2 | chr15 | 28538034 | - | COL5A2 | chr2 | 189940163 | - |
| intron-3CDS | ENST00000563945 | ENST00000374866 | HERC2 | chr15 | 28538034 | - | COL5A2 | chr2 | 189940163 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000261609 | HERC2 | chr15 | 28538034 | - | ENST00000374866 | COL5A2 | chr2 | 189940163 | - | 6046 | 431 | 338 | 3871 | 1177 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000261609 | ENST00000374866 | HERC2 | chr15 | 28538034 | - | COL5A2 | chr2 | 189940163 | - | 0.001026843 | 0.99897313 |
Top |
Fusion Genomic Features for HERC2-COL5A2 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for HERC2-COL5A2 |
| Go to FGviewer for the breakpoints of chr15:28538034-chr2:189940163 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| . | COL5A2 |
| FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Type V collagen is a member of group I collagen (fibrillar forming collagen). It is a minor connective tissue component of nearly ubiquitous distribution. Type V collagen binds to DNA, heparan sulfate, thrombospondin, heparin, and insulin. Type V collagen is a key determinant in the assembly of tissue-specific matrices (By similarity). {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | COL5A2 | chr15:28538034 | chr2:189940163 | ENST00000374866 | 15 | 54 | 1266_1499 | 353.0 | 1500.0 | Domain | Fibrillar collagen NC1 | |
| Tgene | COL5A2 | chr15:28538034 | chr2:189940163 | ENST00000374866 | 15 | 54 | 1067_1069 | 353.0 | 1500.0 | Motif | Cell attachment site | |
| Tgene | COL5A2 | chr15:28538034 | chr2:189940163 | ENST00000374866 | 15 | 54 | 1070_1072 | 353.0 | 1500.0 | Motif | Cell attachment site | |
| Tgene | COL5A2 | chr15:28538034 | chr2:189940163 | ENST00000374866 | 15 | 54 | 1100_1102 | 353.0 | 1500.0 | Motif | Cell attachment site | |
| Tgene | COL5A2 | chr15:28538034 | chr2:189940163 | ENST00000374866 | 15 | 54 | 1127_1129 | 353.0 | 1500.0 | Motif | Cell attachment site | |
| Tgene | COL5A2 | chr15:28538034 | chr2:189940163 | ENST00000374866 | 15 | 54 | 1136_1138 | 353.0 | 1500.0 | Motif | Cell attachment site | |
| Tgene | COL5A2 | chr15:28538034 | chr2:189940163 | ENST00000374866 | 15 | 54 | 506_508 | 353.0 | 1500.0 | Motif | Cell attachment site | |
| Tgene | COL5A2 | chr15:28538034 | chr2:189940163 | ENST00000374866 | 15 | 54 | 944_946 | 353.0 | 1500.0 | Motif | Cell attachment site |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 948_980 | 107.33333333333333 | 4835.0 | Coiled coil | Ontology_term=ECO:0000255 |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 1207_1283 | 107.33333333333333 | 4835.0 | Domain | Cytochrome b5 heme-binding |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 1859_1932 | 107.33333333333333 | 4835.0 | Domain | MIB/HERC2 |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 2759_2936 | 107.33333333333333 | 4835.0 | Domain | DOC |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 4457_4794 | 107.33333333333333 | 4835.0 | Domain | HECT |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 2958_3009 | 107.33333333333333 | 4835.0 | Repeat | RCC1 2-1 |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 3010_3064 | 107.33333333333333 | 4835.0 | Repeat | RCC1 2-2 |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 3065_3116 | 107.33333333333333 | 4835.0 | Repeat | RCC1 2-3 |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 3118_3168 | 107.33333333333333 | 4835.0 | Repeat | RCC1 2-4 |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 3171_3222 | 107.33333333333333 | 4835.0 | Repeat | RCC1 2-5 |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 3224_3274 | 107.33333333333333 | 4835.0 | Repeat | RCC1 2-6 |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 3275_3326 | 107.33333333333333 | 4835.0 | Repeat | RCC1 2-7 |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 3951_4002 | 107.33333333333333 | 4835.0 | Repeat | RCC1 3-1 |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 4004_4056 | 107.33333333333333 | 4835.0 | Repeat | RCC1 3-2 |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 4058_4108 | 107.33333333333333 | 4835.0 | Repeat | RCC1 3-3 |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 4110_4162 | 107.33333333333333 | 4835.0 | Repeat | RCC1 3-4 |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 415_461 | 107.33333333333333 | 4835.0 | Repeat | RCC1 1-1 |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 4164_4214 | 107.33333333333333 | 4835.0 | Repeat | RCC1 3-5 |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 4216_4266 | 107.33333333333333 | 4835.0 | Repeat | RCC1 3-6 |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 4268_4318 | 107.33333333333333 | 4835.0 | Repeat | RCC1 3-7 |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 462_512 | 107.33333333333333 | 4835.0 | Repeat | RCC1 1-2 |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 513_568 | 107.33333333333333 | 4835.0 | Repeat | RCC1 1-3 |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 569_620 | 107.33333333333333 | 4835.0 | Repeat | RCC1 1-4 |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 623_674 | 107.33333333333333 | 4835.0 | Repeat | RCC1 1-5 |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 675_726 | 107.33333333333333 | 4835.0 | Repeat | RCC1 1-6 |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 728_778 | 107.33333333333333 | 4835.0 | Repeat | RCC1 1-7 |
| Hgene | HERC2 | chr15:28538034 | chr2:189940163 | ENST00000261609 | - | 4 | 93 | 2702_2749 | 107.33333333333333 | 4835.0 | Zinc finger | ZZ-type |
| Tgene | COL5A2 | chr15:28538034 | chr2:189940163 | ENST00000374866 | 15 | 54 | 39_97 | 353.0 | 1500.0 | Domain | VWFC |
Top |
Fusion Gene Sequence for HERC2-COL5A2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >In-frame_ENST00000261609_ENST00000374866_TCGA-L9-A5IP_HERC2_chr15_28538034_-_COL5A2_chr2_189940163_length(transcript)=6046nt_BP=431nt GCGCCGGCTGAGCCAGCGGCTCTTGGGAGGCTGCGTCCGCGCGCCGGCGAGGCGAGGCGGCCGGGCCCTGCGCGTCAGGCCTGAGACCTG GGAGGAAGCTGGAGAAAAGATGCCCTCTGAATCTTTCTGTTTGGCTGCCCAGGCTCGCCTCGACTCCAAATGGTTGAAAACAGATATACA GCTTGCATTCACAAGAGATGGGCTCTGTGGTCTGTGGAATGAAATGGTTAAAGATGGAGAAATTGTATACACTGGAACAGAATCAACCCA GAACGGAGAGCTCCCTCCTAGAAAAGATGATAGTGTCGAACCAAGTGGAACAAAGAAAGAAGATCTGAATGACAAAGAGAAAAAAGATGA AGAAGAAACTCCTGCACCTATATATAGGGCCAAGTCAATTCTGGACAGCTGGGTATGGGGCAAGCAACCAGGGACAACGAGGTGCACATG GTATGCCTGGAAAACCTGGACCAATGGGTCCTCTTGGGATACCAGGCTCTTCTGGTTTTCCAGGAAATCCTGGAATGAAGGGAGAAGCAG GTCCTACAGGGGCGCGAGGCCCTGAAGGTCCTCAGGGGCAGAGAGGTGAAACTGGGCCCCCAGGTCCAGTTGGCTCTCCAGGTCTTCCTG GTGCAATAGGAACTGATGGTACTCCTGGTGCCAAAGGCCCAACGGGCTCTCCAGGTACCTCTGGTCCTCCTGGCTCAGCAGGGCCTCCTG GATCTCCAGGACCTCAGGGTAGCACTGGTCCTCAGGGAATTCGAGGCCAACCGGGTGATCCAGGAGTTCCAGGTTTCAAAGGAGAAGCTG GCCCAAAAGGGGAACCAGGGCCACATGGTATTCAGGGTCCGATAGGCCCACCCGGTGAAGAAGGCAAAAGAGGTCCCAGAGGTGACCCAG GAACAGTTGGTCCTCCAGGGCCAGTGGGAGAAAGGGGTGCTCCTGGCAATCGTGGTTTTCCAGGCTCTGATGGTTTACCTGGGCCAAAGG GTGCTCAAGGAGAACGGGGTCCTGTAGGTTCTTCAGGACCCAAAGGAAGCCAGGGGGATCCAGGACGTCCAGGGGAACCTGGGCTTCCAG GTGCTCGGGGTTTGACAGGAAATCCTGGTGTTCAAGGTCCTGAAGGAAAACTTGGACCTTTGGGTGCGCCAGGGGAAGATGGCCGTCCAG GTCCTCCAGGCTCCATAGGAATCAGAGGGCAGCCCGGGAGCATGGGCCTTCCAGGCCCCAAAGGTAGCAGTGGTGACCCTGGGAAACCTG GAGAAGCAGGAAATGCTGGAGTTCCTGGGCAGAGGGGAGCTCCTGGAAAAGATGGTGAAGTTGGTCCTTCTGGTCCTGTGGGCCCGCCGG GTCTAGCTGGTGAAAGAGGAGAACAAGGACCTCCAGGCCCCACAGGTTTTCAGGGGCTTCCTGGTCCTCCAGGGCCTCCTGGAGAAGGTG GAAAACCAGGTGATCAAGGTGTTCCTGGAGATCCCGGAGCAGTTGGCCCGTTAGGACCTAGAGGAGAACGAGGAAATCCTGGGGAAAGAG GAGAACCTGGGATAACTGGACTCCCTGGTGAGAAGGGAATGGCTGGAGGACATGGTCCTGATGGCCCAAAAGGCAGTCCAGGTCCATCTG GGACCCCTGGAGATACAGGCCCACCAGGTCTTCAAGGTATGCCGGGAGAAAGAGGAATTGCAGGAACTCCTGGCCCCAAGGGTGACAGAG GTGGCATAGGAGAAAAAGGTGCTGAAGGCACAGCTGGAAATGATGGTGCAAGAGGTCTTCCAGGTCCTTTGGGCCCTCCAGGTCCGGCAG GTCCTACTGGAGAAAAGGGTGAACCTGGTCCTCGAGGTTTAGTTGGCCCTCCTGGCTCCCGGGGCAATCCTGGTTCTCGAGGTGAAAATG GGCCAACTGGAGCTGTTGGTTTTGCCGGACCCCAGGGTCCTGACGGACAGCCTGGAGTAAAAGGTGAACCTGGAGAGCCAGGACAGAAGG GAGATGCTGGTTCTCCTGGACCACAAGGTTTAGCAGGATCCCCTGGCCCTCATGGTCCTAATGGTGTTCCTGGACTAAAAGGTGGTCGAG GAACCCAAGGTCCGCCTGGTGCTACAGGATTTCCTGGTTCTGCGGGCAGAGTTGGACCTCCAGGCCCTGCTGGAGCTCCAGGACCTGCGG GACCCCTAGGGGAACCCGGGAAGGAGGGACCTCCAGGTCTTCGTGGGGACCCTGGCTCTCATGGGCGTGTGGGAGATCGAGGACCAGCTG GCCCCCCTGGTGGCCCAGGAGACAAAGGGGACCCAGGAGAAGATGGGCAACCTGGTCCAGATGGCCCCCCTGGTCCAGCTGGAACGACCG GGCAGAGAGGAATTGTTGGCATGCCTGGGCAACGTGGAGAGAGAGGCATGCCCGGCCTACCAGGCCCAGCGGGAACACCAGGAAAAGTAG GACCAACTGGTGCAACAGGAGATAAAGGTCCACCTGGACCTGTGGGGCCCCCAGGCTCCAATGGTCCTGTAGGGGAACCTGGACCAGAAG GTCCAGCTGGCAATGATGGTACCCCAGGACGGGATGGTGCTGTTGGAGAACGTGGTGATCGTGGAGACCCTGGGCCTGCAGGTCTGCCAG GCTCTCAGGGTGCCCCTGGAACTCCTGGCCCTGTGGGTGCTCCAGGAGATGCAGGACAAAGAGGAGATCCGGGTTCTCGGGGTCCTATAG GACCACCTGGTCGAGCTGGGAAACGTGGATTACCTGGACCCCAAGGACCTCGTGGTGACAAAGGTGATCATGGAGACCGAGGTGACAGAG GTCAGAAGGGCCACAGAGGCTTTACTGGTCTTCAGGGTCTTCCTGGCCCTCCTGGTCCAAATGGTGAACAAGGAAGTGCTGGAATCCCTG GACCATTTGGCCCAAGAGGTCCTCCAGGCCCAGTTGGTCCTTCAGGTAAAGAAGGAAACCCTGGGCCACTTGGGCCAATTGGACCTCCAG GTGTACGAGGCAGTGTAGGAGAAGCAGGACCTGAGGGCCCTCCTGGTGAGCCTGGCCCACCTGGCCCTCCGGGTCCCCCTGGCCACCTTA CAGCTGCTCTTGGGGATATCATGGGGCACTATGATGAAAGCATGCCAGATCCACTTCCTGAGTTTACTGAAGATCAGGCGGCTCCTGATG ACAAAAACAAAACGGACCCAGGGGTTCATGCTACCCTGAAGTCACTCAGTAGTCAGATTGAAACCATGCGCAGCCCCGATGGCTCGAAAA AGCACCCAGCCCGCACGTGTGATGACCTAAAGCTTTGCCATTCCGCAAAGCAGAGTGGTGAATACTGGATTGATCCTAACCAAGGATCTG TTGAAGATGCAATCAAAGTTTACTGCAACATGGAAACAGGAGAAACATGTATTTCAGCAAACCCATCCAGTGTACCACGTAAAACCTGGT GGGCCAGTAAATCTCCTGACAATAAACCTGTTTGGTATGGTCTTGATATGAACAGAGGGTCTCAGTTCGCTTATGGAGACCACCAATCAC CTAATACAGCCATTACTCAGATGACTTTTTTGCGCCTTTTATCAAAAGAAGCCTCCCAGAACATCACTTACATCTGTAAAAACAGTGTAG GATACATGGACGATCAAGCTAAGAACCTCAAAAAAGCTGTGGTTCTCAAAGGGGCAAATGACTTAGATATCAAAGCAGAGGGAAATATTA GATTCCGGTATATCGTTCTTCAAGACACTTGCTCTAAGCGGAATGGAAATGTGGGCAAGACTGTCTTTGAATATAGAACACAGAATGTGG CACGCTTGCCCATCATAGATCTTGCTCCTGTGGATGTTGGCGGCACAGACCAGGAATTCGGCGTTGAAATTGGGCCAGTTTGTTTTGTGT AAAGTAAGCCAAGACACATCGACAATGAGCACCACCATCAATGACCACCGCCATTCACAAGAACTTTGACTGTTTGAAGTTGATCCTGAG ACTCTTGAAGTAATGGCTGATCCTGCATCAGCATTGTATATATGGTCTTAAGTGCCTGGCCTCCTTATCCTTCAGAATATTTATTTTACT TACAATCCTCAAGTTTTAATTGATTTTAAATATTTTTCAATACAACAGTTTAGGTTTAAGATGACCAATGACAATGACCACCTTTGCAGA AAGTAAACTGATTGAATAAATAAATCTCCGTTTTCTTCAATTTATTTCAGTGTAATGAAAAAGTTGCTTAGTATTTATGAGGAAATTCTT CTTCCTGGCAGGTAGCTTAAAGAGTGGGGTATATAGAGCCACAACACATGTTTATTTTGCTTGGCTGCAGTTGAAAAATAGAAATTAGTG CCCTTTTGTGACCTCTCATTCCAAGATTGTCAATTAAAAATGAGTTTAAAATGTTTAACTTGTGATCGAGACCTACATGCATGTCTTGAT ATTGTGTAACTATAATAGAGACTCTTTAAGGAGAATCTTAAAAAAAAAAAAACGTTTCTCACTGTCTTAAATAGAATTTTTAAATAGTAT ATATTCAGTGGCATTTTGGAGAACAAAGTGAATTTACTTCGACTTCTTAAATTTTTGTAAAAGACTATAAGTTTAGACATCTTTCTCATT CAAATTTAAAGATATCTTTCTCCTCTTGATCAATCTATCAATATTGATAGAAGTCACACTAGTATATACCATTTAATACATTTACACTTT CTTATTTAAGAAGATATTGAATGCAAAATAATTGACATATAGAACTTTACAAACATATGTCCAAGGACTCTAAATTGAGACTCTTCCACA TGTACAATCTCATCATCCTGAAGCCTATAATGAAGAAAAAGATCTAGAAACTGAGTTGTGGAGCTGACTCTAATCAAATGTGATGATTGG AATTAGACCATTTGGCCTTTGAACTTTCATAGGAAAAATGACCCAACATTTCTTAGCATGAGCTACCTCATCTCTAGAAGCTGGGATGGA CTTACTATTCTTGTTTATATTTTAGATACTGAAAGGTGCTATGCTTCTGTTATTATTCCAAGACTGGAGATAGGCAGGGCTAAAAAGGTA TTATTATTTTTCCTTTAATGATGGTGCTAAAATTCTTCCTATAAAATTCCTTAAAAATAAAGATGGTTTAATCACTACCATTGTGAAAAC ATAACTGTTAGACTTCCCGTTTCTGAAAGAAAGAGCATCGTTCCAATGCTTGTTCACTGTTCCTCTGTCATACTGTATCTGGAATGCTTT GTAATACTTGCATGCTTCTTAGACCAGAACATGTAGGTCCCCTTGTGTCTCAATACTTTTTTTTTCTTAATTGCATTTGTTGGCTCTATT TTAATTTTTTTCTTTTAAAATAAACAGCTGGGACCATCCCAAAAGACAAGCCATGCATACAACTTTGGTCATGTATCTCTGCAAAGCATC AAATTAAATGCACGCTTTTGTCATGTCAGTGGTTTTTGTTTTGTGAAATTCCTTTGACCATATTAGATCTATTTCATTTCCAATAGTGAA AAGGAGATGTGGTGGTATACTTTGTTTGCCATTTGTTTAAAAGATACAACGGATACCTTCTATCATGTATGTACTGGCTTATAAATGAAA ATCTATCTACAACATTACCCACAAAGGCAACATGACACCAATTATCACTGCCTCTGCCCTTAAAAATGTCAGAGTAGTATTATTGATAAA AAGGGCAAGCAATAGATTTTTCATGACTGAATAAACTGTAATAATAAAACATATGTCTCAAAGTGTATCACATATGAATTTAGCCTAATT GTTTTCAGTTTCATTCTCAATATTTAGTTTACAACATCATTTTCCCCTAAACTGGTTATATTTTGACCTGTATATCTTAAATTTGAGTAT TTATATGCCTAAATACATGTGTGAGTTTTGTTTGACTTCCAAGTCCAAACTATAAGATTATATAAGTTCATATAGATGAATCAGAAATAT GTGGTAATACTATTAAGTCACAAACACTAACAATTTCCAACTATAGAAATAACAGTTCTTATTTGGATTTTGGGAATGCTACCAATAAAA >In-frame_ENST00000261609_ENST00000374866_TCGA-L9-A5IP_HERC2_chr15_28538034_-_COL5A2_chr2_189940163_length(amino acids)=1177AA_start in transcript=338_stop in transcript=3871 MTKRKKMKKKLLHLYIGPSQFWTAGYGASNQGQRGAHGMPGKPGPMGPLGIPGSSGFPGNPGMKGEAGPTGARGPEGPQGQRGETGPPGP VGSPGLPGAIGTDGTPGAKGPTGSPGTSGPPGSAGPPGSPGPQGSTGPQGIRGQPGDPGVPGFKGEAGPKGEPGPHGIQGPIGPPGEEGK RGPRGDPGTVGPPGPVGERGAPGNRGFPGSDGLPGPKGAQGERGPVGSSGPKGSQGDPGRPGEPGLPGARGLTGNPGVQGPEGKLGPLGA PGEDGRPGPPGSIGIRGQPGSMGLPGPKGSSGDPGKPGEAGNAGVPGQRGAPGKDGEVGPSGPVGPPGLAGERGEQGPPGPTGFQGLPGP PGPPGEGGKPGDQGVPGDPGAVGPLGPRGERGNPGERGEPGITGLPGEKGMAGGHGPDGPKGSPGPSGTPGDTGPPGLQGMPGERGIAGT PGPKGDRGGIGEKGAEGTAGNDGARGLPGPLGPPGPAGPTGEKGEPGPRGLVGPPGSRGNPGSRGENGPTGAVGFAGPQGPDGQPGVKGE PGEPGQKGDAGSPGPQGLAGSPGPHGPNGVPGLKGGRGTQGPPGATGFPGSAGRVGPPGPAGAPGPAGPLGEPGKEGPPGLRGDPGSHGR VGDRGPAGPPGGPGDKGDPGEDGQPGPDGPPGPAGTTGQRGIVGMPGQRGERGMPGLPGPAGTPGKVGPTGATGDKGPPGPVGPPGSNGP VGEPGPEGPAGNDGTPGRDGAVGERGDRGDPGPAGLPGSQGAPGTPGPVGAPGDAGQRGDPGSRGPIGPPGRAGKRGLPGPQGPRGDKGD HGDRGDRGQKGHRGFTGLQGLPGPPGPNGEQGSAGIPGPFGPRGPPGPVGPSGKEGNPGPLGPIGPPGVRGSVGEAGPEGPPGEPGPPGP PGPPGHLTAALGDIMGHYDESMPDPLPEFTEDQAAPDDKNKTDPGVHATLKSLSSQIETMRSPDGSKKHPARTCDDLKLCHSAKQSGEYW IDPNQGSVEDAIKVYCNMETGETCISANPSSVPRKTWWASKSPDNKPVWYGLDMNRGSQFAYGDHQSPNTAITQMTFLRLLSKEASQNIT YICKNSVGYMDDQAKNLKKAVVLKGANDLDIKAEGNIRFRYIVLQDTCSKRNGNVGKTVFEYRTQNVARLPIIDLAPVDVGGTDQEFGVE -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for HERC2-COL5A2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for HERC2-COL5A2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for HERC2-COL5A2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | HERC2 | C3809753 | MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38 | 2 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
| Hgene | HERC2 | C0009324 | Ulcerative Colitis | 1 | CTD_human |
| Hgene | HERC2 | C0264423 | Asthma, Occupational | 1 | CTD_human |
| Tgene | COL5A2 | C4538407 | EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2 | 4 | GENOMICS_ENGLAND;UNIPROT |
| Tgene | COL5A2 | C4552122 | EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1 | 3 | GENOMICS_ENGLAND |
| Tgene | COL5A2 | C0220679 | Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified | 2 | ORPHANET |
| Tgene | COL5A2 | C3151201 | MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME | 2 | GENOMICS_ENGLAND |
| Tgene | COL5A2 | C0000786 | Spontaneous abortion | 1 | CTD_human |
| Tgene | COL5A2 | C0000822 | Abortion, Tubal | 1 | CTD_human |
| Tgene | COL5A2 | C0005779 | Blood Coagulation Disorders | 1 | GENOMICS_ENGLAND |
| Tgene | COL5A2 | C0023890 | Liver Cirrhosis | 1 | CTD_human |
| Tgene | COL5A2 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
| Tgene | COL5A2 | C0239946 | Fibrosis, Liver | 1 | CTD_human |
| Tgene | COL5A2 | C0268335 | Ehlers-Danlos syndrome type 1 | 1 | GENOMICS_ENGLAND |
| Tgene | COL5A2 | C0268336 | Ehlers-Danlos syndrome type 2 | 1 | GENOMICS_ENGLAND |
| Tgene | COL5A2 | C1458140 | Bleeding tendency | 1 | GENOMICS_ENGLAND |
| Tgene | COL5A2 | C1846545 | Autoimmune Lymphoproliferative Syndrome Type 2B | 1 | GENOMICS_ENGLAND |
| Tgene | COL5A2 | C3830362 | Early Pregnancy Loss | 1 | CTD_human |
| Tgene | COL5A2 | C4225429 | Ehlers-Danlos syndrome classic type | 1 | GENOMICS_ENGLAND |
| Tgene | COL5A2 | C4552766 | Miscarriage | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies